However, only when the TNFSF14 molecule is delivered to or expressed within tumors can it exert the synergistic effect with immune checkpoint inhibitors, thereby activating the ability of immune cells to kill tumor cells (Skeate et al., 2020). The gene discussed is TNFSF14; the disease is neoplasm.